Evidence map›Paper›PMID 41548061›Full record

ArticleChemistry & biodiversity2026

Phenolic Profile, Antioxidant Potential, and Antidiabetic Effects of Aristolochia longa Extracts in Streptozotocin-Induced Diabetic Rats.

Ikram Benahmed, Mokhtar Benabderrahmane, Houria Medjdoub, Salim Habi, Safaa Ziane, Said Ghalem

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ikram BenahmedDepartment of Biology, Laboratory of Biotoxicology, Faculty of Natural and Life Sciences, Djillali Liabes University of Sidi Bel Abbes, Algeria.ORCID https://orcid.org/0009-0006-5910-3954
Mokhtar BenabderrahmaneDepartment of Biology, Laboratory of Biotoxicology, Faculty of Natural and Life Sciences, Djillali Liabes University of Sidi Bel Abbes, Algeria.
Houria MedjdoubDepartment of Biology, Laboratory of Antifungal, Antibiotic, Physicochemical, Synthesis and Biological Activity, Faculty of Natural and Life Sciences, Earth and Universe Sciences, University of Abou Bekr Belkaid Tlemcen, Algeria.
Salim HabiDepartment of Biology, Laboratory of Physiology, Pathophysiology and Biochemistry of Nutrition, Faculty of Natural and Life Sciences, Earth and Universe Sciences, University of Abou Bekr Belkaid Tlemcen, Algeria.
Safaa ZianeLaboratory of Natural and Bioactive Substances, Faculty of Science, University of Abou Bekr Belkaid Tlemcen, Algeria.
Said GhalemLaboratory of Natural and Bioactive Substances, Faculty of Science, University of Abou Bekr Belkaid Tlemcen, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aristolochia longa, a medicinal plant traditionally used in folk medicine, exhibits remarkable pharmacological properties primarily attributed to its bioactive-rich rhizomes. This study aimed to evaluate its phytochemical composition, in vitro antioxidant capacity, α-amylase inhibitory potential, and in vivo antidiabetic effects. Antioxidant assays, including 2,2-diphenyl-1-picrylhydrazyl, β-carotene bleaching, and ferric reducing antioxidant power, revealed strong activity with 50% inhibitory concentration (IC

Indexed as

AntioxidantsDiabetes Mellitus, ExperimentalHypoglycemic AgentsPhenolsPlant Extractsalpha-AmylasesAnimalsBlood GlucoseDose-Response Relationship, DrugMaleRatsRats, WistarStreptozocinalpha-AmylasesAntioxidantsBlood GlucoseHypoglycemic AgentsPhenolsPlant ExtractsStreptozocinantidiabetic activityantioxidant activityAristolochia longalipid profileα‐amylase inhibition

Identifiers

PMID41548061
PMCPMC13420817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.